UNSPSC 51361800: Hypnotic azoles

Hypnotic drugs made from five membered rings containing a nitrogen atom.

UNSPSC 51361800 Hypnotic azoles is a Class code, but the recent state and local opportunities tagged under it do not center on hypnotic azole pharmaceuticals. Instead, the opportunities reflect broader pharmaceutical procurement and opioid-response initiatives: Seminole County, Florida is acquiring naloxone and drug deactivation systems for community health; the Texas Health and Human Services Commission is gathering market intelligence on direct-to-manufacturer prescription programs; and the Minnesota Multistate Cooperative Purchasing Alliance (MMCAP) is soliciting generic multi-source pharmaceuticals and over-the-counter products across state and local facilities in Minnesota and Oregon. The issuing-body mix spans county health departments, state health agencies, and cooperative purchasing consortia. The scope of work reflects public-sector pharmaceutical procurement for clinical use and harm reduction rather than a single narrow drug class.

Geographic activity appears concentrated in the South and Midwest. Seminole County, Florida posted an IFB (IFB60459723LAS) with a response deadline of July 26, 2023, seeking 1,900 units of naloxone and 800 safe drug deactivation systems annually with quarterly deliveries. The Texas HHS Commission issued a Request for Information (RFI HHS0017013) on April 3, 2026, to assess vendor capacity for direct-to-manufacturer prescription contracting outside traditional pharmacy benefit manager and group purchasing organization channels. MMCAP, administered by the Minnesota Department of Administration, released an RFP (S1070000015802) with a March 26, 2026, response deadline for generic multi-source pharmaceutical and OTC product supply across authorized wholesalers, with contract pricing weighted 75 percent on competitiveness and requiring compliance with current Good Manufacturing Practices and the Drug Supply Chain Security Act. The code shows modest recent activity, with opportunities driven by specific state health initiatives and cooperative purchasing rather than sustained demand across numerous jurisdictions.